Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today ...

Premium Global Income Split Corp. has declared monthly distributions payable on January 31, 2025 to shareholders of record on January 15, 2025 in the following amounts per share: Share ...